SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is rallying following a significant order for its wafer-level burn-in systems from a major silicon photonics customer, signaling a transition toward high-volume production for AI data center infrastructure. The stock remains a heavily debated AI infrastructure play, with the community actively split between bulls betting on multi-year growth in chip testing demand and bears pointing to high valuation multiples relative to current revenue.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is experiencing a historic sell-off as a revenue miss and a shift in enterprise spending toward AI infrastructure over software and consulting trigger widespread investor concern. The community is actively debating whether the 25% drop is an extreme overreaction to a short-term spending shift or a fundamental breakdown of the company's long-term business model.

SK hynix, Inc. engages in the manufacture and sale of semiconductor products. Its products include dynamic random access memory, flash memory, complementary metal oxide semiconductor image sensor, and others. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix is seeing intense volatility following its recent U.S. ADR debut, with the community fiercely debating whether the stock's significant premium over its South Korean listing signals a structural re-rating or a temporary bubble ripe for an arbitrage correction. Investors remain divided between bullish sentiment fueled by AI memory demand and HBM supply constraints, and bearish concerns regarding the impact of Korean market leverage, margin calls, and the potential for a technical rug-pull following the IPO excitement.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is experiencing intense volatility and downward pressure as investors weigh concerns over heavy capital expenditure and debt against its significant cloud and AI backlog. Community sentiment remains deeply divided, with some traders actively betting on a short squeeze or long-term value recovery, while others express frustration over the lack of communication from leadership during the ongoing slide.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

Celcuity is currently trending as investors monitor its transition to a commercial-stage oncology company following the FDA approval of its breast cancer therapy, Revtorpyk. While the market is debating the short-term price action and potential for institutional buyouts, the community remains focused on the drug's strong efficacy data and the company's improved financial position to execute its commercial launch.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike is trending following an earnings report that featured strong revenue performance but left investors divided over the company's valuation and ARR growth expectations. While the community is actively debating whether the stock's massive rally is due for a healthy consolidation or if the cybersecurity sector remains a critical long-term AI infrastructure play, sentiment is split between those viewing the pullback as a buying opportunity and others concerned about its premium price-to-earnings multiple.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors react to the recently scheduled FDA advisory committee meeting for Deramiocel and ongoing legal battles regarding commercialization rights. While some community members express concern over regulatory uncertainty and potential litigation impacts, many bulls are actively accumulating shares, viewing the current price action as a strategic shakeout before anticipated catalysts.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and the public react to ongoing geopolitical instability, including renewed military operations in the Middle East and debates over the administration's economic policies. Community discussion is highly polarized, with intense focus on the company's financial performance, legal controversies surrounding its leadership, and speculation regarding future stock volatility.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as investors debate the impact of the World Cup on betting volume and the potential for prediction markets to drive long-term growth. While some community members highlight significant betting activity and institutional interest as bullish catalysts, others express frustration over stagnant price action and increased competition in the gaming space.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as the community debates its long-term potential, with bulls pointing to the project's evolving role in payroll and AI-driven payments alongside major ecosystem partnerships. While some investors are actively accumulating and staking in anticipation of future adoption, others remain skeptical, voicing concerns about price stagnation and the project's ability to scale effectively.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CLLS Stock Rallies Over 24% After Hours — Here's Why

Equity

FDA granted Regenerative Medicine Advanced Therapy (RMAT) designation to Cellectis’s investigational cell therapy.


Cellectis (CLLS) to Release Quarterly Earnings on Monday

Cellectis (NASDAQ:CLLS) will be releasing its Q1 2026 earnings after the market closes on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-cellectis-sa-stock...

Cellectis (NASDAQ:CLLS) Stock Price Crosses Below 200 Day Moving Average - Time to Sell?

Cellectis (NASDAQ:CLLS) Stock Price Crosses Below 200 Day Moving Average - Here's What Happened...

Cellectis (NASDAQ:CLLS) Shares Pass Below 200-Day Moving Average   - Time to Sell?

Cellectis (NASDAQ:CLLS) Stock Price Passes Below 200 Day Moving Average - Should You Sell...

Cellectis (NASDAQ:CLLS) Given Market Outperform Rating at Citizens Jmp

Citizens Jmp reiterated a "market outperform" rating and issued a $8.00 price objective on shares of Cellectis in a research note on Tuesday...

Cellectis S.A. (NASDAQ:CLLS) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Cellectis S.A. (NASDAQ:CLLS - Get Free Report) have been given an average rating of "Moderate Buy" by the five ratings firms that are presently covering the stock, Marketbeat Ratings...

Allogene Arbitration Victory Pressures Cellectis Shares Tuesday

Cellectis shares fell after Allogene cited a favorable arbitration ruling confirming control of cema-cel and outlining key CAR-T milestones.read more...

Cellectis (NASDAQ:CLLS) Share Price Crosses Above Fifty Day Moving Average - Here's Why

Cellectis (NASDAQ:CLLS) Stock Passes Above Fifty Day Moving Average - Should You Sell...

Why Cellectis Stock Is Trading Higher Today

Cellectis reports strong Nature Communications data showing CssDNA boosts non-viral gene insertion efficiency and supports long-term therapeutic potential.read more...

Cellectis (NASDAQ:CLLS) Shares Cross Above Fifty Day Moving Average - Should You Sell?

Cellectis (NASDAQ:CLLS) Stock Crosses Above 50 Day Moving Average - Here's Why...

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.

Cellectis - ADR

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$2.88
Prev Close	$2.90
Open	$2.95
Dividend Yield	0.00%
50-Day Moving Average	$3.36
Beta	1.12
Avg. Volume	48,965.73
PE Ratio	-4.31

52-Week High	$5.48
52-Week Low	$1.77
Market Capitalization	$209.74M
EPS (Annual)	-$0.6761
Price to Book	4.87
Revenue Per Employee	$319,540.26

Feed

News

Sentiment

Earnings

Fundamentals

Info

CLLSCellectis

Latest CLLS News